Phase II Trial of Paclitaxel Combined With Trastuzumab and Pertuzumab as Pre-Operative Therapy for Inflammatory Breast Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Jul 2017
At a glance
- Drugs Pertuzumab (Primary) ; Cyclophosphamide; Doxorubicin; Paclitaxel; Trastuzumab
- Indications Inflammatory breast cancer
- Focus Therapeutic Use
- 30 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jun 2017 Biomarkers information updated
- 27 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Jun 2018.